Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹-247 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr
Mar2021₹-186 Cr
Mar2020₹-251 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr
Positive
Mar2021 ₹-186 Cr
Negative
Mar2020 ₹-251 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,042.3 Cr -4.6% -38.8% -22.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 3.9% -3.2% 3.1% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 1.8% -4.5% 53.9% Stock Analytics
CIPLA ₹117,415.0 Cr -0.6% -0.3% -2.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 1.2% -3% 14.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -3% -9.5% -11.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.6%

-38.8%

-22.3%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses